September 2026
Interferon-alpha Drug Converts Mutant Blood Stem Cells into Short-Lived Immune Cells
A study by Weill Cornell Medicine reveals that the drug interferon-alpha can help patients with blood cancers by converting mutant blood stem cells into shorter-lived…
New Insights into Metabotropic Glutamate Receptors Could Enhance Treatment for Brain Disorders
Two studies led by Weill Cornell Medicine have revealed complex interactions of metabotropic glutamate receptors with regulatory proteins, which could lead to better drug targeting…
Study Links Disrupted Stress Hormones to Unique Obesity Type
A study by Weill Cornell Medicine reveals that obesity from disrupted stress-hormone rhythms differs metabolically from obesity due to high-fat diets, impacting insulin resistance in…
Blocking a Protein May Help Combat Aging-Related Health Issues
Researchers at Cedars-Sinai Health Sciences University have discovered a protein that may enable aging cells to evade the immune system, potentially leading to increased age-related…
Common genetic marker linked to accelerated progression of Parkinson's disease
A study by the Mass General Brigham Neuroscience Institute identified genetic variants in the MC1R gene linked to faster progression of Parkinson's disease. This discovery…
Spleen Imaging May Indicate Risk for Coronary Artery Disease: Implications for Healthcare
A study from Mass General Brigham indicates that specific features in spleen imaging can predict coronary artery disease risk, highlighting potential prevention and treatment strategies.…
Experimental Drug Shows Potential in Treating Systemic Sclerosis
Researchers at Cedars-Sinai Health Sciences University have developed an experimental drug that shows promise in reversing systemic sclerosis, an autoimmune disease. This study, published in…
New Framework Enhances Genetic Disease Risk Prediction Accuracy
Researchers at Cedars-Sinai Health Sciences University have created a new computational framework to enhance the accuracy of predicting genetic disease risks, including Alzheimer's and breast…
New Tool Developed to Measure Anxiety in Thyroid Cancer Patients
Cedars-Sinai Health Sciences University has developed the Thyroid Cancer Modified Anxiety Scale (TC-MAX), the first tool to measure anxiety in thyroid cancer patients. This advancement…
Pentagon Investigates Military Leaks Related to Iran through Polygraph Tests
The Pentagon is investigating leaks related to the war with Iran and US munitions shortages by conducting polygraph tests on about 50 Joint Staff members.…
AI Enhancements in Breast Cancer Detection: Implications and Limitations
A review by UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence could assist radiologists in detecting breast cancers that mammograms may miss, although…
Less-Intensive Drug Combination Proves More Effective for Acute Myeloid Leukemia
Investigators from the Mass General Brigham Cancer Institute discovered that a less-intensive drug combination of azacitidine and venetoclax is more effective for adults with newly…
Antifungal Therapy Shows Promise for IBD Patients with Candida Overgrowth
A study by Weill Cornell Medicine suggests that a systemic antifungal medication may alleviate symptoms in some inflammatory bowel disease (IBD) patients by improving gut…
L-glutamine Supplement Enhances Survival in Advanced Pancreatic Cancer Patients
A clinical trial led by Cedars-Sinai Health Sciences University showed that adding L-glutamine to standard chemotherapy improved survival rates for patients with advanced pancreatic cancer.…
New Treatment Shows Promise in Reducing Heart Damage in Severe Heart Attack Patients
A clinical trial conducted by the Cardiovascular Imaging Research Center at Indiana University demonstrated that intravenous dexrazoxane can reduce intramyocardial hemorrhage in severe heart attack…